Abstract Library

Welcome to the open-access search for all ENETS abstracts presented at the Annual ENETS Conferences.

Everyone can browse the library to find basic information on abstracts. To get full access to each entry, you will be asked to log in to your myENETS account.

 

Please note:

Participants of the 2025 ENETS Conference enjoy full access to the 2025 conference digital resources through myENETS: the abstract booklet, e-posters and videos, slide decks of talks, the poster carousel, and more.

Log in to myENETS

ENETS Abstract Search

#4478 Association between serum biomarkers and liver tumour burden in advanced gastroenteropancreatic neuroendocrine tumours

Introduction: The association between serum biomarker levels and tumour burden is less studied in GEP-NET.

Conference:

Presenting Author: Jumai N

Authors: Jumai N, Chen L, Yusufu Y, Yan X, Liu M,

Keywords: Neuroendocrine tumour, tumour burden, prognosis, biomarker,

#4313 Identification of gastroenteropancreatic neuroendocrine tumour patients with high liver tumour burden based on clinicopathological features

Introduction: Metastatic liver tumour burden (LTB) is a prognostic factor affecting the survival of gastroenteropancreatic neuroendocrine tumours (GEP-NETs), but evaluation of the LTB usually depends on radiologic and functional imaging.

Conference:

Presenting Author:

Authors: Jumai N, Chen L, Liu M, He Q, Zeng Z,

Keywords: liver tumour burden, prognosis, GEP-NET,

#4038 Identification of gastroenteropancreatic neuroendocrine tumor with high liver tumor burden based on clinicopathological features

Introduction: Liver tumor burden (LTB) is a key prognostic factor affecting survival and treatment response of GEP-NET patients. Currently available quantitative assessment of LTB relies on 68Ga-SSA PET/CT scan which is not accessible in some centers.

Conference:

Presenting Author: Chen L

Authors: Jumai N, Chen L, He Q, Liu M, Wen W,

Keywords: liver tumor burden, prediction, neuroendocrine tumor,

#3661 Blood liver enzyme levels correlate with hepatic tumor burden in advanced neuroendocrine tumors

Introduction: Abnormal levels of blood liver enzymes, including hepatic liver enzymes alanine aminotransferase (ALT) or aspartate aminotransferase (AST), and cholestatic liver enzymes alkaline phosphatase (ALP) or gamma-glutamyl transpeptidase (GGT)can be found in some patients with advanced neuroendocrine tumors (NETs), but the clinical relevance is less understood.

Conference:

Presenting Author:

Authors: Chen L, Jumai N, Liu M, He Q, Lin Y,

Keywords: neuroendocrine tumor, hepatic tumor burden, liver enzyme, overall survival,